Meeting
2023 ASCO Genitourinary Cancers Symposium
Does body mass index matter in predicting renal mass sizes? Comparison of imaging modalities.
Authors
Young Son
Jefferson New Jersey, Philadelphia, PA
Young Son , Benjamin Fink , Brian Thomas , Dayna DeVincentz , Raeann Dalton , Thomas Mueller , Gordon Andrew Brown
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 619)
DOI
10.1200/JCO.2023.41.6_suppl.619
Abstract #
619
Poster Bd #
E9
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Growth kinetics and progression rates of cystic renal masses on active surveillance.
First Author: Justin Tse
Poster
2016 Genitourinary Cancers Symposium
Study of PSMA-targeted 18F-DCFPyL PET/CT in the evaluation of men with an elevated PSA following radical prostatectomy.
First Author: Michael A. Gorin
Poster
2024 ASCO Annual Meeting
From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.
First Author: Mengmeng Ji
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Predicting rapid progression and overall survival in stage II-III pancreatic cancer using a CT-based radiomic signature.
First Author: Qinmei Xu